Search Results - Hardern, Chloë

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Cost-effectiveness of pembrolizumab for the first-line treatment of patients with unresectable or metastatic MSI-H/dMMR colorectal cancer in the United States

    Cost-effectiveness of pembrolizumab for the first-line treatment of patients with unresectable or metastatic MSI-H/dMMR colorectal cancer in the United States by Aguiar-Ibáñez, Raquel, Hardern, Chloë, van Hees, Frank, Lee, Dawn, Patel, Anubhav, Chhabra, Nitika, Baluni, Gargi, Amonkar, Mayur, Lai, Yizhen, Xu, Ruifeng, Massaad, Rachid, Fogelman, David

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Cost-Effectiveness of Vedolizumab as a First-Line Advanced Therapy Versus Adalimumab Treatment Sequences for Ulcerative Colitis in Italy

    Cost-Effectiveness of Vedolizumab as a First-Line Advanced Therapy Versus Adalimumab Treatment Sequences for Ulcerative Colitis in Italy by Salcedo, Jonathan, Hill-McManus, Daniel, Hardern, Chloë, Opeifa, Oyin, Viti, Raffaella, Siviero, Ludovica, Roscini, Antonio Saverio, Di Martino, Gennaro

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: